-
EOFlow Officially Launches iOS Version of the EOPatch App ‘Narsha’
▶ iOS version of the world’s first app for controlling wearable insulin pump ▶ Improved ease of use by replacing a portable controller with a smartphone app EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, today announces that it officially launches iOS Version of ‘Narsha,’ a smartphone application for wearable insulin pump in Korea. It has been nine months since the Company officially launched the Android application of Narsha. Narsha is the world’s first...May. 17. 2022 -
EOFlow Announces Record Revenue for First Quarter 2022; Revenue of 949 Million KRW which is 137% of Last Year’s Annual Revenue
▶ Highest-ever quarterly revenue! Strong revenue growth from European sales; Menarini will progressively launch the product in Europe from 2Q22 onwards! ▶ EOFlow expects significant growth in revenue in 2022 from market launches in Europe, Indonesia, and the Middle East EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, announced its Q1 financial results ended on March 31, 2022. EOFlow announced its consolidated financial results: first quarter of 2022 revenue of 949 million Korean...May. 16. 2022 -
EOFlow Has its First Clinical Study on EOPatch Published in Diabetes & Metabolism Journal
▶ A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus ▶ 4-week treatment with EOPatch was safe and led to clinically meaningful improvement in glycemic control compared to those with MDI or conventional insulin pump EOFlow Co. Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced today that its first clinical study results on the wearable insulin pump EOPatch in patients with type 1 diabetes were publ...Apr. 11. 2022 -
EOFlow to Supply KRW48.8bn Worth of EOPatch to Gulf Drug of UAE
▶ A Major Export Deal for EOFlow’s Innovative Insulin Pump EOPatch EOFlow Co. Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has announced on March 31 that it has signed a contract with GulfDrug LLC (Gulf Drug) of the United Arab Emirates (UAE) to supply 48.8 billion Korean won (40 million US dollar) worth of EOPatch, a disposable and wearable insulin pump, over the course of five years. The Company said the contract amount is equivalent to 7043 percent (%) of its entire sales last year. T...Apr. 04. 2022 -
EOFLOW and K-Bio Health sign an MOU
K-Bio Health and EOFLOW sign an MOU to cooperate in developing and commercializing wearable automated insulin delivery solutions. K-Bio Health is one of the largest healthcare-focused development & testing labs supported by the Korean Ministry of Health. You can read more about the news at one of the links below, all of which are in Korean only: http://www.biospectator.com/view/news_view.php?varAtcId=6281 http://www.mdtoday.co.kr/mdtoday/index.html?no=333586 http://www.yakup.com/news/index.html?mode=view&nid=222513 http://www.dailymedi....Oct. 01. 2018 -
EOFLOW's product chosen as a 'Top 100 Science Spinoffs'
EOFLOW was recently informed that SPINOFF.COM had chosen EOFLOW's 'tiny wearable artificial pancreas' as one of 'the Top 100 Science Spinoffs.' The product has 'entered 2 % out of 5,000 global science spinoffs according to the following criteria: uniqueness of the technology/product, high commercial potential and positive impact to the humanity’s well-being,' according to SPINOFF.COM. You can find out more about SPINOFF.COM here: http://www.spinoff.com You can read about us on SPINOFF.COM here: http://w...Aug. 16. 2018 -
EOFLOW mentioned as a major new medical device company in an article
EOFLOW was mentioned as one of four medical device companies in Korea developing world-class product by Hankyung, a major economic newspaper in Korea. Read the article with this link (in Korean only): http://news.hankyung.com/health/article?aid=2018080661121Aug. 09. 2018 -
EOFLOW will be at the 2018 EASD, Berlin, Germany (10/2 - 10/4)
EOFLOW will exhibit at the 2018 54th EASD (European Association for the Study of Diabetes) held in Berlin, Germany, 10/02 - 10/04/2018. EOFLOW's booth is 3.Q02. Please contact us in advance if you'd like to arrange a meeting with our marketing team: info@eoflow.comAug. 06. 2018 -
EOFLOW presents to President Moon
EOFLOW presented its company and product to President Moon of Korea who visited our campus today. Pres. Moon announced a major overhaul program on the medical device regulations at the campus. EOFLOW was given the opportunity to present itself to Pres. Moon and a group of high-level government officials including the Minister of Health and Welfare and Minister of Small and Medium Enterprises afterward. The news is covered by almost all major news outlets, and here are a few of those links: Yonhap News Agency: http://www.yonha...Jul. 19. 2018 -
EOFLOW's JDRF partnership chosen as a top-10 event
The recent announcement of partnership between JDRF and EOFLOW in developing an integrated wearable automated insulin delivery system makes news again. This time, the JDRF support was chosen as one of the '10 Events that Rattled Medtech in 1Q18' by MD+DI (Medical Device + Diagnostic Industry) newsletter. You can read about us and 9 other significant events here: https://www.mddionline.com/top-10-medtech-stories-1q18Jul. 04. 2018 -
EOFLOW will be at the 2018 ADA, Orlando (6/23-25)
EOFLOW will exhibit its EOPatch wearable disposable insulin delivery product (and more) at the 2018 American Diabetic Association's 78th Scientific Session held in Orlando, Florida, 6/23 - 6/25/2018. EOFLOW's booth is 423. Please contact us in advance if you'd like to arrange a meeting with our marketing team: info@eoflow.comJun. 20. 2018 -
EOFLOW covered in a major newspaper article
Maeil Business News Korea (www.mk.co.kr), one of the most widely read economics newspapers in Korea, discusses EOFLOW's wearable insulin pump in its article covering the new medical trend of focusing on improved user experience. To read the Korean article, click the link below: http://news.mk.co.kr/newsRead.php?year=2018&no=343754May. 31. 2018 -
EOFLOW investment story on TV
MTN (Money Today Network), one of the most popular financial TV networks in Korea, runs a story on how Huons Global, EOFLOW's exclusive distribution partner in Korea, invests in EOFLOW in its in-depth story that covers the recent trend of established Korean bio and pharma companies identifying and investing in promising startup biotech companies. The video clip and text of the clip can be found in the link here, in Korean only: http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018052111062224948 &n...May. 28. 2018 -
EOFLOW closes two back-to-back rounds of funding
EOFLOW announces the closing of its Series-C and C+ rounds of funding. Through this unusual back-to-back funding rounds with two different valuations (with the C+ being higher than the C-round that closed unannounced a month earlier), the company has raised a total of 14Billion KRW (about $14M) from four investors, of which two are existing shareholders of EOFLOW. With the latest rounds of funding, combined with the recent award from JDRF (Juvenile Diabetes Research Foundation) and some fresh gove...May. 04. 2018
Healthcare Innovation Park #H2202 Dolma-ro 172 Bundang-gu Seongnam-si Gyeonggi-do Republic of Korea
T (+82) 031-738-0200
F (+82) 031-738-0208
COPYRIGHT ⓒ 2017 EOFLOW CO., LTD. All Rights Reserved.
